Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
about
Recommended Therapeutic INR Range for Patients with Antiphospholipid Syndrome on Warfarin Anticoagulation: Is Moderate-Intensity (INR 2.0 - 3.0) or High-Intensity (INR 3.1 - 4.0) Better for Reducing Risk of Recurrent Thromboembolic Events?Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulant.Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies.Impact of Classical Risk Factors for Arterial or Venous Thrombosis in Patients With Antiphospholipid Syndrome.The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome.
P2860
Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Patients with antiphosholipid ...... n (the Piedmont cohort study).
@en
type
label
Patients with antiphosholipid ...... n (the Piedmont cohort study).
@en
prefLabel
Patients with antiphosholipid ...... n (the Piedmont cohort study).
@en
P2093
P2860
P356
P1433
P1476
Patients with antiphosholipid ...... n (the Piedmont cohort study).
@en
P2093
A Vaccarino
B Montaruli
D Roccatello
M T Bertero
Piedmont APS Consortium
R Carignola
S Sciascia
P2860
P304
P356
10.1177/0961203315617538
P577
2015-12-08T00:00:00Z